XML 94 R84.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income (Loss) Per Common Share - Computation of Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Earnings Per Share [Abstract]        
Income (loss) from continuing operations $ 2,123 $ (13,040) $ (7,352) $ (33,337)
Income (loss) from discontinued operations, net of tax [1] 0 0 (463) 1,383
Net income (loss) attributable to common shareholders of Evolent Health, Inc. 2,123 (13,040) (7,815) (31,954)
Net income (loss) attributable to common shareholders of Evolent Health, Inc. $ 2,123 $ (13,040) $ (7,815) $ (31,954)
Weighted-average common shares outstanding - basic 95,286 85,800 91,643 85,306
Incremental diluted shares from stock options 1,915 0 0 0
Incremental diluted shares from Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs") 2,107 0 0 0
Convertible notes 0 0 0 0
Weighted-average common shares outstanding - diluted 99,308 85,800 91,643 85,306
Basic:        
Continuing operations, basic (in dollars per share) $ 0.02 $ (0.15) $ (0.08) $ (0.39)
Discontinued operations, basic (in dollars per share) 0 0 (0.01) 0.02
Basic income (loss) per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) 0.02 (0.15) (0.09) (0.37)
Diluted:        
Continuing operations, diluted (in dollars per share) 0.02 (0.15) (0.08) (0.39)
Discontinued operations, diluted (in dollars per share) 0 0 (0.01) 0.02
Diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share) $ 0.02 $ (0.15) $ (0.09) $ (0.37)
[1] Includes $(0.5) million loss on disposal of discontinued operations for the nine months ended September 30, 2022 and $1.9 million gain on disposal of discontinued operations for the nine months ended September 30, 2021, respectively